Prevention of adult pneumococcal pneumonia with the 13-valent pneumococcal conjugate vaccine: CAPiTA, the community-acquired pneumonia immunization trial in adults

被引：15
|
作者：
Isturiz, Raul [1 ]
Webber, Chris [2 ]
机构：
[1] Pfizer Vaccine Res, Collegeville, PA 19426 USA
[2] Pfizer Vaccine Clin Res, Maidenhead, Berks, England
来源：
HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2015年 / 11卷 / 07期
关键词：
POLYSACCHARIDE VACCINE; DISEASE; IMMUNOGENICITY; CHILDREN; SAFETY; IMPACT;
D O I：
10.1080/21645515.2015.1043502
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：1825 / 1827
页数：3
相关论文
共 50 条
  • [1] The Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Carriage in the Community Acquired Pneumonia Immunization Trial in Adults (CAPiTA) Study
    van Deursen, Anna M. M.
    van Houten, Marlies A.
    Webber, Chris
    Patton, Michael
    Scott, Daniel
    Patterson, Scott
    Jiang, Qin
    Gruber, William C.
    Schmoele-Thoma, Beate
    Grobbee, Diederick E.
    Beaten, Marc J. M.
    Sanders, Elisabeth A. M.
    [J]. CLINICAL INFECTIOUS DISEASES, 2018, 67 (01) : 42 - 49
  • [2] Immunogenicity of the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults With and Without Comorbidities in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA)
    van Deursen, Anna M. M.
    van Houten, Marlies A.
    Webber, Chris
    Patton, Michael
    Scott, Daniel A.
    Patterson, Scott
    Sidhu, Mohinder
    Drews, Wayne
    Gruber, William C.
    Emini, Emilio A.
    Grobbee, Diederick E.
    Bonten, Marc J. M.
    Sanders, Elisabeth A. M.
    [J]. CLINICAL INFECTIOUS DISEASES, 2017, 65 (05) : 787 - 795
  • [3] Impact of the 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia and pneumococcal pneumonia in children in Japan
    Ishiwada, Naruhiko
    Naito, Sachiko
    Takeuchi, Noriko
    Ohkusu, Misako
    Nagasawa, Koo
    Abe, Katsuaki
    Omata, Yuko
    Hishiki, Haruka
    Hoshino, Tadashi
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S46 - S46
  • [4] Community-acquired pneumonia in the post 13-valent pneumococcal conjugate vaccine era
    Shaughnessy, Erin E.
    Stalets, Erika L.
    Shah, Samir S.
    [J]. CURRENT OPINION IN PEDIATRICS, 2016, 28 (06) : 786 - 793
  • [5] Early Impact of 13-Valent Pneumococcal Conjugate Vaccine on Community-Acquired Pneumonia in Children
    Angoulvant, F.
    Levy, C.
    Grimprel, E.
    Varon, E.
    Lorrot, M.
    Biscardi, S.
    Minodier, P.
    Dommergues, M. A.
    Hees, L.
    Gillet, Y.
    Craiu, I.
    Zenkhri, F.
    Dubos, F.
    Gras-Le Guen, C.
    Launay, E.
    Martinot, A.
    Cohen, R.
    [J]. CLINICAL INFECTIOUS DISEASES, 2014, 58 (07) : 918 - 924
  • [6] The potential role of 13-valent pneumococcal conjugate vaccine in preventing respiratory complications in bacteraemic pneumococcal community-acquired pneumonia
    Sanz-Herrero, Francisco
    Gimeno-Cardona, Concepcion
    Tormo-Palop, Nuria
    Fernandez-Fabrellas, Estrella
    Luisa Briones, Maria
    Cervera-Juan, Angela
    Blanquer-Olivas, Jose
    [J]. VACCINE, 2016, 34 (15) : 1847 - 1852
  • [7] The Community-Acquired Pneumonia immunization Trial in Adults (CAPiTA): what is the future of pneumococcal conjugate vaccination in elderly?
    van Werkhoven, Cornelis H.
    Bonten, Marc J. M.
    [J]. FUTURE MICROBIOLOGY, 2015, 10 (09) : 1405 - 1413
  • [8] 13-Valent pneumococcal conjugate vaccine (PCV13) serotypes in adults with community acquired pneumonia in Taiwan
    Chang, S. C.
    Li, C. T.
    Cheng, S. L.
    Gray, S.
    Gonzalez, E.
    Pride, M.
    Sebastian, S.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2015, 45 : S119 - S119
  • [9] The impact of 13-valent pneumococcal conjugate vaccination on virus-associated community-acquired pneumonia in elderly Exploratory analysis of the CAPiTA trial
    Huijts, S. M.
    Coenjaerts, F. E. J.
    Bolkenbaas, M.
    van Werkhoven, C. H.
    Grobbee, D. E.
    Bonten, M. J. M.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2018, 24 (07) : 764 - 770
  • [10] Potential Role Of Pneumococcal 13-Valent Vaccine In Preventing Respiratory Complications In Pneumococcal Bacteremic Community-Acquired Pneumonia
    Novella Sanchez, L.
    Sanz Herrero, F.
    Concepcion, G.
    Fernandez-Fabrellas, E.
    Tormo, N.
    Chiner, E.
    Briones, M.
    Aguar, M.
    Cervera, A.
    Blanquer, J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
12345